Article
INSAID Variant Classification and Eurofever Criteria Guide Optimal Treatment Strategy in Patients with TRAPS: Data from the Eurofever Registry.
The journal of allergy and clinical immunology. In practice - 1 Feb 2021
Papa Riccardo, Lane Thirusha, Minden Kirsten, Touitou Isabelle, Cantarini Luca, Cattalini Marco, Obici Laura, Jansson Annette F, Belot Alexandre, Frenkel Joost, Anton Jordi, Wolska-Kusnierz Beata, Berendes Rainer, Remesal Agustin, Jelusic Marija, Hoppenreijs Esther, Espada Graciela, Nikishina Irina, Maggio Maria Cristina, Bovis Francesca, Masini Marta, Youngstein Taryn, Rezk Tamer, Papadopoulou Charalampia, Brogan Paul A, Hawkins Philip N, Woo Patricia, Ruperto Nicolino, Gattorno Marco, Lachmann Helen J
Abstract excerpt
BACKGROUND: TNF receptor-associated periodic syndrome (TRAPS) is a rare autoinflammatory disease caused by dominant mutation of the TNF super family receptor 1A (TNFRSF1A) gene. Data regarding long-term treatment outcomes are lacking. OBJECTIVE: To assess correlations of genotype-phenotypes in patients with TRAPS, as defined by the International Study Group for Systemic Autoinflammatory Diseases (INSAID)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.